Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 9/20/2019 9:00:00 PM
A new mode of #drugdelivery for retinal diseases: Drug-eluting contacts: #ophthalmology
BCH Innovation News @BCH_Innovation 9/20/2019 6:00:01 PM
Most retinal diseases today require painful eye injections or implants that carry potential side effects. A new…
BCH Innovation News @BCH_Innovation 9/20/2019 12:00:01 PM
.@MassEyeAndEar & @BostonChildrens develop a contact lens that delivers drugs all the way to the back of the eye:…
BCH Innovation News @BCH_Innovation 9/19/2019 7:00:01 PM
#Drugeluting contact lenses for retinal diseases pass key preclinical tests - via @Biomaterials:…
BCH Innovation News @BCH_Innovation 9/19/2019 3:30:01 PM
A big step forward in identifying #autism in infancy, when it’s most amenable to intervention:…
BCH Innovation News @BCH_Innovation 9/19/2019 12:56:01 PM
RT @mandl: Proud of the @BostonChildrens Computational Health Informatics Program @bos_chip turning 25 this year, and looking forward to we…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer